Ozempic Injury Suits Consolidated In Eastern Pa. MDL

By P.J. D'Annunzio · February 5, 2024, 6:49 PM EST

The Judicial Panel on Multidistrict Litigation has moved 55 MDL cases over Ozempic and similar drugs to the Eastern District of Pennsylvania, centralizing the litigation that claims Novo Nordisk A/S and...

To view the full article, register now.

Documents

Case Information

Case Title

IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation

Case Number

3094

Court

Judicial Panel on Multidistrict Litigation

Nature of Suit

Date Filed

December 01, 2023